ADIPOQ showed significant enrichment in immune regulatory pathways, including B cell receptor signaling and autoimmune thyroid disease, suggesting a potential role in modulating immune responses within the IA microenvironment. This evidence concerns the gene ADIPOQ and autoimmune thyroid disease.